Research behind.png

Welcome to our Research Behind Infection Prevention segment, where Dr. Mohamed Yassin provides tough questions to top researchers and leaders in their field.

listen at google.png

Podcast – Episode 42


Dr. Sarah Wheeler who has developed and validated antibody assays for SARS-CoV-2 explains antibody testing. If you ever had any questions about antibody testing, she explains it all.

June 10, 2021

Dr. Sarah Wheeler is an Assistant Professor at the University of Pittsburgh, Department of Pathology, Medical Director of Clinical Chemistry at Children’s Hospital of Pittsburgh of UPMC, Medical Director of the Automated Testing Laboratory at Mercy Hospital, and Associate Medical Director of Clinical Immunopathology at UPMC.  Her research interests include infectious disease serology screening assays (SARS CoV2, HIV, syphilis, lyme, hepatitis), rapid point of care diagnostics, and appropriate serology testing in children with immune dysregulation.  Dr. Wheeler completed her doctoral work at the University of Pittsburgh in cellular and molecular pathology.  She completed a combined basic research and clinical post-doctoral fellowship at the University of Pittsburgh in metastatic breast cancer and clinical chemistry respectively.  Since her post-doctoral fellowship Dr. Wheeler has worked in both industry and academic medical centers, combining research and clinical duties.  She is credentialed by the National Registry of Certified Chemists and is a Fellow of the AACC Academy. 



Research articles referenced in the podcast: 

Dr. Wheeler co-authored: Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening


Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study


Dr. Sarah Wheeler, PhD

​Best way to reach Dr. Wheeler: